Alasdair Thong
Founding Partner at Selvedge Venture
London, England
Overview
Work Experience
Head of Sovereign Innovation
2025 - Current
Leading strategic partnerships at the national level, enabling developing bioeconomies to rapidly build sustainable, end-to-end biotechnology ecosystems. Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners across academia, biotech, and the largest biopharma, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, genetic medicines, peptides, cell therapies, and drug delivery. https://alloytx.com
Board Observer
2025
representing Mubadala Capital
Alloy Therapeutics is a biotech company that makes medicine by democratizing access to foundational drug discovery platforms and services.
Raised $128,250,000.00 from 8VC, Presight Capital, Founders Fund, Thiel Capital and Mubadala Capital Ventures.
Co-Founder and Non-Executive Director
2021
Multiomic Health is a next-generation precision medicine venture, integrating computational systems biology with laboratory science to develop and commercialize new therapeutics for metabolic syndrome — the world’s largest healthcare burden. https://multiomic.health
BD, Licensing, Acquisitions and Investments
2024
The Ellison Institute of Technology’s mission is to develop and deploy technology in pursuit of solving some of humanity’s most challenging and enduring problems. Guided by world leaders, scientists and entrepreneurs, EIT seeks to accelerate innovation in health and medical science, food security and sustainable agriculture, climate change and clean energy, and government innovation and era of artificial intelligence. https://eit.org
Venture Partner
2020
Mubadala Capital is the wholly owned asset management arm of Mubadala Investment Company with over USD$16 billion AUM. Mubadala is an Abu Dhabi sovereign wealth investor with USD$250bn+ AUM. https://www.mubadala.com/en/what-we-do/capital/ventures
Venture Partner: Healthcare
2020
Ada Ventures is the inclusive venture firm. Ada Ventures finds and funds extraordinary talent building breakthrough ideas for the hardest problems we face. We are investing out of our second fund and we invest £250,000 - £1m in UK technology companies across climate, economic empowerment and healthcare & ageing. If you are raising seed capital for your start-up you can apply directly below: Fundraising: https://adaventures.typeform.com/AdaSubmissions https://www.adaventures.com/
Founding Partner
2019
Selvedge Venture is a Venture Capital management and advisory firm with a focus on deep tech in life sciences and healthcare. https://selvedgeventure.com
Investor
2023
via Mubadala Capital
Metsera develops oral and injectable therapies for obesity and metabolic diseases.
Raised $505,000,000.00 from SymBiosis, Deep Track Capital, Viking Global Investors, Alpha Wave Ventures, T. Rowe Price, Newpath Management, Venrock Healthcare Capital Partners, T. Rowe Price Japan, Google Ventures and Fidelity.
Board Observer
2021
Investor/Advisor
2021
Investor
2021